Correspondence

Unavailability of intravesical BCG for treatment of bladder cancer

A letter from Professor Sir Mike Richards, National Clinical Director for Cancer.

Documents

See letter on unavailability of intravesical BCG for treatment of bladder cancer

This file may not be suitable for users of assistive technology. Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@dh.gsi.gov.uk . Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

A letter from Professor Sir Mike Richards, National Clinical Director for Cancer, provides information and sources of further guidance relating to the current shortage of products used in the treatment of some bladder cancers.

Published 9 July 2012